Human glomerulonephritis (GN) and its glomerulosclerotic (GS) sequela are a major cause of renal failure necessitating expensive dialysis and transplantation therapy. Better understanding of the immune pathogenesis and therapeutic manipulation of the underlying molecular mechanisms of sclerosis would stall buildup of extracellular matrix (ECM) and loss of nephron units in GS. Two areas of this problem will be studied from a molecular perspective: 1) the reactive epitopes/V-gene interactions and possible abnormalities of alpha3 (IV) collagen chains in anti-glomerular basement membrane (GBN) antibody (Ab) GN and Alport syndrome as well as assessment of protein-protein interactions with the alpha-chains; 2) the role of ECM proteinases and their inhibitors in excess accumulation of ECM in GS. The genomic DNA for the carboxyl terminal NCI domain of alpha3(lV) collagen, a major anti-GBM Ab Ag, was cloned with evidence of alternatively spliced mRNAs which vary relative to one another during kidney development. The carboxyl terminal variations predicted by the alternatively spliced mRNAs may be control mechanisms and could help to explain Ag variations among patients as well as structural abnormalities in GBM of patients with Alport syndrome in whom alpha3 (IV) Ag may be missing. A combination of synthetic peptides, biochemical fractions, and expressed recombinant fragments, including unique deduced peptides from the spliced mRNAs of alpha3(IV) and their reactive Abs, will help define anti-GBM Ab epitopes and their variations in normal and Alport GBM. The epitope knowledge will be related to the V-gene composition of the autoantibody as an avenue to immunospecific treatment. Inhibitors (PAI 1, TIMPs) of ECM proteinases may impair ECM degradation during sclerosis. The role of the proteinases (u-PA, transin) and their inhibitors, as well as often associated coagulation proteins, will be sought in manipulative experimental studies (including mice transgenic for PAI 1 and transin) and in immunocytochemical and molecular studies in human renal biopsies. These studies will document molecular and enzymatic abnormalities in GN and GS and set the stage for evaluation of molecular therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DK020043-23
Application #
6380404
Study Section
Special Emphasis Panel (NSS)
Program Officer
Hirschman, Gladys H
Project Start
1977-04-01
Project End
2002-11-30
Budget Start
2001-07-01
Budget End
2002-11-30
Support Year
23
Fiscal Year
2001
Total Cost
$400,220
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Fujinaka, H; Yamamoto, T; Feng, L et al. (2007) Anti-perforin antibody treatment ameliorates experimental crescentic glomerulonephritis in WKY rats. Kidney Int 72:823-30
Garcia, Gabriela E; Xia, Yiyang; Ku, George et al. (2003) IL-18 translational inhibition restricts IFN-gamma expression in crescentic glomerulonephritis. Kidney Int 64:160-9
Garcia, Gabriela E; Xia, Yiyang; Harrison, Jeffrey et al. (2003) Mononuclear cell-infiltrate inhibition by blocking macrophage-derived chemokine results in attenuation of developing crescentic glomerulonephritis. Am J Pathol 162:1061-73
Narsipur, Sriram S; Peterson, Orjan W; Smith, Robert et al. (2003) Mechanisms of glomerular immune injury: effects of antioxidant treatment. J Am Soc Nephrol 14:1748-55
Tang, W W; Feng, L; Loskutoff, D J et al. (2000) Glomerular extracellular matrix accumulation in experimental anti-GBM Ab glomerulonephritis. Nephron 84:40-8
Feng, L; Garcia, G E; Yang, Y et al. (2000) Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats. J Clin Invest 105:341-50
Feng, L; Chen, S; Garcia, G E et al. (1999) Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int 56:612-20
Hirose, S; Yamamoto, T; Feng, L et al. (1998) Expression and localization of cyclooxygenase isoforms and cytosolic phospholipase A2 in anti-Thy-1 glomerulonephritis. J Am Soc Nephrol 9:408-16
Schwartz, D; Mendonca, M; Schwartz, I et al. (1997) Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100:439-48
Fujinaka, H; Yamamoto, T; Feng, L et al. (1997) Crucial role of CD8-positive lymphocytes in glomerular expression of ICAM-1 and cytokines in crescentic glomerulonephritis of WKY rats. J Immunol 158:4978-83

Showing the most recent 10 out of 42 publications